FIELD: biotechnology, oncology.
SUBSTANCE: invention relates to preparing a new novel human melanoma cellular line mel IL that possesses stable cultural and morphological indices and stored in the Specialized collection of vertebrate cell cultures of Russian collection of cellular cultures at number PKKK (P) 686D. The novel prepared cellular line is characterized by expression of melanoma (differentiating) markers - CD-63, HMB-45, HMW, MelanA, Tyrozinaza and cancer-testicular marker MAGE-3 also. Invention provides enhancing the effectiveness of antitumor (all-cell, genetic engineering) vaccines used in treatment of melanoma and other malignant neoplasms. Invention can be used in creature of antitumor vaccines.
EFFECT: valuable medicinal properties of melanoma line.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
HUMAN MELANOMA CELLULAR LINE mel Kor USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287578C1 |
HUMAN MELANOMA CELLULAR LINE mel P USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287575C1 |
CELL LINE OF HUMAN MELANOMA mel H, APPLIED FOR OBTAINING ANTITUMOUR VACCINE | 2009 |
|
RU2402604C1 |
HUMAN MELANOMA CELL LINE mel Gus, USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2373280C1 |
HUMAN MELANOMA CELL LINE mel Ch, USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2373279C1 |
HUMAN MELANOMA CELL LINES mel Si, USED FOR MAKING TUMOUR VACCINE | 2008 |
|
RU2363734C1 |
HUMAN MELANOMA CELLULAR LINE mel Ibr USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287576C1 |
CELL LINE OF HUMAN MELANOMA mel Rac, APPLIED FOR OBTAINING ANTITUMOUR VACCINE | 2009 |
|
RU2402602C1 |
HUMAN MELANOMA CELL LINE mel Bgf USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2390557C1 |
CELL LINE OF HUMAN MELANOMA mel Mtp USED FOR MAKING ANTICANCER VACCINES | 2008 |
|
RU2360963C1 |
Authors
Dates
2006-11-20—Published
2005-04-22—Filed